<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00026936</url>
  </required_header>
  <id_info>
    <org_study_id>990116</org_study_id>
    <secondary_id>99-C-0116</secondary_id>
    <nct_id>NCT00026936</nct_id>
  </id_info>
  <brief_title>A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning</brief_title>
  <official_title>A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a
      clinical setting will be assessed by comparing results with other fully three-dimensional
      programs. ROB will investigate PEREGRINE for clinical use at NCI in collaboration with
      Lawrence Livermore National Laboratory (LLNL).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a
      clinical setting will be assessed by comparing results with other fully three-dimensional
      programs. ROB will investigate PEREGRINE for clinical use at NCI.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 1999</start_date>
  <completion_date>January 2005</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <enrollment>140</enrollment>
  <condition>Neoplasm</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiotherapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA:

        Patients with documented malignancy requiring standard radiotherapy OR patients with a
        benign condition for whom radiotherapy is indicated.

        EXCLUSION CRITERIA:

        Documented connective tissue disease or Ataxia Telangiectasia.

        Cognitively impaired patients who cannot give informed consent.

        Other medical conditions deemed by the PI to make the patient ineligible.

        Patients requiring emergent radiotherapy.

        Patients who are not able to undergo a CT scan.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>National Cancer Institute (NCI)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Perez CA, Purdy JA, Harms W, Gerber R, Graham MV, Matthews JW, Bosch W, Drzymala R, Emami B, Fox S, et al. Three-dimensional treatment planning and conformal radiation therapy: preliminary evaluation. Radiother Oncol. 1995 Jul;36(1):32-43.</citation>
    <PMID>8525023</PMID>
  </reference>
  <reference>
    <citation>Lawrence TS, Ten Haken RK, Kessler ML, Robertson JM, Lyman JT, Lavigne ML, Brown MB, DuRoss DJ, Andrews JC, Ensminger WD, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys. 1992;23(4):781-8.</citation>
    <PMID>1618671</PMID>
  </reference>
  <reference>
    <citation>Yorke ED, Kutcher GJ, Jackson A, Ling CC. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol. 1993 Mar;26(3):226-37.</citation>
    <PMID>8316652</PMID>
  </reference>
  <verification_date>January 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2001</study_first_submitted>
  <study_first_submitted_qc>November 14, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2001</study_first_posted>
  <last_update_submitted>March 3, 2008</last_update_submitted>
  <last_update_submitted_qc>March 3, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2008</last_update_posted>
  <keyword>External Beam Radiotherapy</keyword>
  <keyword>TCP</keyword>
  <keyword>DVH</keyword>
  <keyword>NTCP</keyword>
  <keyword>3-D Programming</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

